FDA Drugs recall ·

Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII… recall

Recall number
D-0178-2026
Date
(initiated September 23, 2025)
Company / brand
Park Avenue Compounding
3662 Park Ave Ste 140, Saint Louis, MO, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
189 bags
Hazard tags
Manufacturing practices (cGMP)
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.

Why was it recalled?

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot # 20250507-01D93C, Exp Date: 11-04-2025

Distribution

Distributed in Missouri

States: Missouri

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0178-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.